DEVELOPMENT OF A BIOMARKER FOR LUNG INFLAMMATION IN COPD THROUGH ANALYSIS OF LABELLED LEUKOCYTE TRANSIT THROUGH THE LUNG CIRCULATION

WINNING ABSTRACT: Measurement of pulmonary leukocyte margination could be a useful biomarker of lung inflammation in COPD, but analysis is complicated by recirculation of labeled leukocytes. 15 minutes of planar nuclear images were obtained after injecting autologous 99mTc-labeled leukocytes in 4 never-smoked controls, 6 stable mild/moderate and 2 exacerbating COPD patients. COPD patients were also imaged for 10 minutes after in vivo red blood cell (RBC) labeling with 99mTc and were re-imaged 2 weeks later to determine reproducibility. Activity as a function of time was measured in regions of interest over lungs and heart. A multi-compartment mathematical model was used to correct for recirculation but failed to provide a biomarker that clearly separated controls from COPD. A simpler model for activity in lungs and heart as a function of time (A(t)) was applied only to time points before recirculation: [A(t)5X1 x (1-exp(-X2 x t)) x exp(-X3 x t), where Xi are adjusted to match the data]. The ratio (R) of X3 (downslope of curve) in the lungs to X3 in the heart was investigated as a biomarker of margination. Values of R were reasonable (1.06¡0.08 (SE)) for RBC (i.e. no margination) and 0.76¡0.10 for controls (,25 % margination). In stable COPD patients R was significantly smaller (0.19¡0.09, p,0.01) than controls and was reproducible (0.25¡0.10). R during exacerbation was surprisingly large (0.88¡0.22), possibly due to steroid treatment, but R was similar to stable COPD patients 2 weeks later (0.09¡0.04). R requires only 2–3 minutes of imaging and may be a useful biomarker of margination. However it remains to be shown whether R truly reflects inflammation in COPD